相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan
Hazim O. Khalifa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Repurposing of Ribavirin as an Adjunct Therapy against Invasive Candida Strains in an In Vitro Study
Hanane Yousfi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Short-Course Rather Than Low-Dose Amphotericin B May Exert Potential Influence on Mortality in Cryptococcal Meningitis Patients Treated With Amphotericin B Plus Flucytosine Alone or in Combination With Fluconazole
Lijun Xu et al.
FRONTIERS IN MICROBIOLOGY (2019)
Improvement of fungal disease identification and management: combined health systems and public health approaches
Donald C. Cole et al.
LANCET INFECTIOUS DISEASES (2017)
Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance
Kelley R. Healey et al.
NATURE COMMUNICATIONS (2016)
Role of FKS Mutations in Candida glabrata: MIC Values, Echinocandin Resistance, and Multidrug Resistance
Cau D. Pham et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia
Nicholas D. Beyda et al.
CLINICAL INFECTIOUS DISEASES (2014)
Breakthrough Invasive Candida glabrata in Patients on Micafungin: a Novel FKS Gene Conversion Correlated with Sequential Elevation of MIC
Takeshi Saraya et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
Barbara D. Alexander et al.
CLINICAL INFECTIOUS DISEASES (2013)
It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug
Ana C. Mesa-Arango et al.
Frontiers in Microbiology (2012)
Multilaboratory Testing of Two-Drug Combinations of Antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis
Vishnu Chaturvedi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections
Cassandra Moran et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2010)
Synergistic Activities of Three Triazoles with Caspofungin against Candida glabrata Isolates Determined by Time-Kill, Etest, and Disk Diffusion Methods
Nuri Kiraz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Caspofungin in combination with amphotericin B against Candida parapsilosis
Francesco Barchiesi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B -: Clearance with voriconazole
C Antachopoulos et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2005)
Combination treatment of invasive fungal infections
PK Mukherjee et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Combination antifungal therapy
MD Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata
F Barchiesi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects
JH Rex et al.
CLINICAL INFECTIOUS DISEASES (2003)
Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction - Chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome
GN Mattiuzzi et al.
CANCER (2003)
In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach
DTAT Dorsthorst et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species
RE Lewis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Interactions of posaconazole and flucytosine against Cryptococcus neoformans
F Barchiesi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis
A Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
分享论文
